Drug Combo Tolerated in Younger Children With Cystic Fibrosis
Lumacaftor/ivacaftor safe in children ages 2 to 5 with cystic fibrosis homozygous for F508del-CFTR
Postconditioning During PCI for STEMI Shows Delayed Benefits
Benefits at one year include reduced microvascular obstruction, improved left ventricular remodeling
FDA Approves Cablivi for Rare Blood-Clotting Disorder
Drug approved to treat adults with acquired thrombotic thrombocytopenic purpura
Patient Tested for Ebola at Philadelphia Hospital
Testing was done out of 'an abundance of caution'
EEG-Guided Anesthesia Does Not Cut Postop Delirium in Seniors
Significantly less median cumulative time found with EEG suppression in EEG-guided group vs. usual care
Recommendations Updated for Tonsillectomy in Children
Strong recommendations presented against administering perioperative antibiotics, codeine after tonsillectomy
Omadacycline Noninferior to Moxifloxacin for Pneumonia
Second study shows noninferiority to linezolid for acute bacterial skin and skin-structure infections
Value-Based Incentive Program Does Not Cut Catheter-Linked UTIs
VBIP implementation not linked with immediate changes or changes in trends for any outcome
Type 2 Diabetes Risk Up With PCOS Regardless of BMI
PCOS one of most influential predictors of T2DM after adjustment for BMI, education, family history
ERAS Protocol Can Cut Opioid Use After Spine Surgery
Decline seen in postoperative opioid requirements after elective spinal, peripheral nerve surgery
